Rekombinanter BTLA Antikörper
Kurzübersicht für Rekombinanter BTLA Antikörper (ABIN7828035)
Target
Alle BTLA Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Recombinant CD272/BTLA Monoclonal Antibody
-
Aufreinigung
- Protein A purified
-
Isotyp
- IgG, kappa
-
-
-
-
Applikationshinweise
- WB 1:1000-1:3000,IF 1:50
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Andere Bezeichnung
- CD272/BTLA
-
Hintergrund
- MGC,B and T lymphocyte attenuator,B and T lymphocyte associated protein,BTLA,BTLA1,CD272,B and T lymphocyte associated protein,B and T lymphocyte attenuator,B and T lymphocyte associated,B- and T-lymphocyte attenuator,B- and T-lymphocyte-associated protein,CD272 antigen,FLJ16065,MGC129743,This gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in this gene have been associated with an increased risk of rheumatoid arthritis. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [
-
Molekulargewicht
-
Calculated MW: 33 kDa
Observed MW: 55 kDa The actual band is not consistent with the expectation.
-
UniProt
- Q7Z6A9
-
Pathways
- Cancer Immune Checkpoints
Target
-